The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen

✍ Scribed by Henderson, Emily J; Lord, Stephen R; Close, Jacqueline CT; Lawrence, Andrew D; Whone, Alan; Ben-Shlomo, Yoav

• Book ID: 121579028
• Publisher: BioMed Central
• Year: 2013
• Tongue: English
• Weight: 264 KB
• Volume: 13
• Category: Article
• ISSN: 1471-2377
• DOI: 10.1186/1471-2377-13-188